Back to Search Start Over

Pre-existing conditions associated with post-acute sequelae of COVID-19.

Authors :
Jacobs ET
Catalfamo CJ
Colombo PM
Khan SM
Austhof E
Cordova-Marks F
Ernst KC
Farland LV
Pogreba-Brown K
Source :
Journal of autoimmunity [J Autoimmun] 2023 Feb; Vol. 135, pp. 102991. Date of Electronic Publication: 2023 Jan 06.
Publication Year :
2023

Abstract

Post-acute sequelae of COVID-19 (PASC) are conditions that occur or remain at least 28 days after SARS-CoV-2 infection. While some risk factors for PASC have been identified, little is known about pre-existing conditions that render one susceptible to developing PASC. Data from participants (n = 1224) in a longitudinal COVID-19 cohort study in Arizona were used to investigate comorbid conditions associated with PASC. After adjustment of the models for age, BMI, gender, race, and smoking, the following pre-existing conditions were statistically significantly associated with the development of PASC: asthma (OR = 1.54; 95% CI = 1.10-2.15); chronic constipation (OR = 4.29; 95% CI = 1.15-16.00); reflux (OR = 1.54; 95% CI = 1.01-2.34); rheumatoid arthritis (OR = 3.69; 95%CI = 1.15-11.82); seasonal allergies (OR = 1.56; 95% CI = 1.22-1.98); and depression/anxiety (OR = 1.72; 95% CI = 1.17-2.52). When grouping conditions together, statistically significant associations with PASC were observed for respiratory (OR = 1.47; 95% CI = 1.06-2.14); gastrointestinal (OR = 1.62; 95% CI = 1.16-2.26), and autoimmune conditions (OR = 4.38; 95% CI = 1.59-12.06). After adjustment for severity of acute SARS-CoV-2 infection and depression/anxiety, seasonal allergies (OR = 1.48; 95% CI 1.15-1.91) and autoimmune disease (OR = 3.78; 95% CI - 1.31-10.91) remained significantly associated with risk for PASC. These findings indicate that numerous pre-existing conditions may be associated with an increased risk for the development of PASC. Patients with these conditions should consider taking extra steps to avoid infection.<br />Competing Interests: Declaration of competing interest The authors report there are no competing interests to declare.<br /> (Copyright © 2023 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1095-9157
Volume :
135
Database :
MEDLINE
Journal :
Journal of autoimmunity
Publication Type :
Academic Journal
Accession number :
36634460
Full Text :
https://doi.org/10.1016/j.jaut.2022.102991